QCM Cayman’s Celgene Corp CELG Stock Holding History

QCM Cayman’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-19,900	Closed	-$2.48M	–	496
2017 Q1	$2.48M	Buy	+19,900	New	+$2.38M	0.47%	49
2016 Q4	–	Sell	-10,200	Closed	-$1.07M	–	288
2016 Q3	$1.07M	Buy	+10,200	New	+$1.1M	1.18%	17
2016 Q2	–	Sell	-3,500	Closed	-$350K	–	398
2016 Q1	$350K	Buy	+3,500	New	+$360K	0.24%	66
2015 Q4	–	Sell	-2,700	Closed	-$292K	–	306
2015 Q3	$292K	Sell	2,700 -12,000	-82%	-$1.49M	0.1%	121
2015 Q2	$1.7M	Buy	14,700 +12,500	+568%	+$1.43M	0.65%	28
2015 Q1	$254K	Buy	+2,200	New	+$263K	0.14%	135
2014 Q4	–	Sell	-14,000	Closed	-$1.33M	–	338
2014 Q3	$1.33M	Hold	14,000	–	–	0.31%	35
2014 Q2	$1.2M	Sell	14,000 -4,000	-22%	-$304K	0.58%	34
2014 Q1	$1.26M	Buy	18,000 +7,800	+76%	+$618K	0.28%	50
2013 Q4	$862K	Sell	10,200 -5,000	-33%	-$396K	0.28%	41
2013 Q3	$1.17M	Buy	+15,200	New	+$1.07M	0.71%	31

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM Cayman's CELG Position: Q3 2018 in Review

QCM Cayman sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 4,691 shares — an estimated $373K sold.

QCM Cayman first reported a position in CELG in Q1 2014 and held it in 4 quarters. The position peaked at $1.49M in Q2 2016. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

QCM Cayman reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
QCM Cayman sold 4,691 Celgene Corp shares in Q3 2018, an estimated $373K.
QCM Cayman first reported a position in Celgene Corp in Q1 2014 and held it in 4 quarters.
QCM Cayman's Celgene Corp position peaked at $1.49M in Q2 2016.
1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on QCM Cayman's 13F filing for Q3 2018, filed 14 Nov 2018.